Browse AMR Genes
Explore antimicrobial resistance genes from the literature
Explore antimicrobial resistance genes from the literature
Overview
| Protein Change | Nucleotide Change | Mechanism | Organism | Resistance To | Database | Validation Status |
|---|---|---|---|---|---|---|
| Q678L | - | elongation factor G FusA1 | Pseudomonas aeruginosa, Acinetobacter baumannii | AMIKACIN/TOBRAMYCINTobramycin | Reference Gene CatalogReslit | Confirmed |
| A595P | - | elongation factor G FusA1 | Pseudomonas aeruginosa | TOBRAMYCIN | Reference Gene Catalog | Established |
| T671I | - |
| elongation factor G FusA1 |
| Pseudomonas aeruginosa |
AMIKACIN/TOBRAMYCINAminoglycoside |
Reference Gene CatalogReslit |
| Confirmed |
| E100G | - | elongation factor G FusA1 | Pseudomonas aeruginosa | AMIKACIN/TOBRAMYCINAminoglycoside | Reference Gene CatalogReslit | Confirmed |
| Q455R | - | elongation factor G FusA1 | Pseudomonas aeruginosa | AMIKACIN/TOBRAMYCIN | Reference Gene Catalog | Established |
| K504Q | - | elongation factor G FusA1 | Pseudomonas aeruginosa | AMIKACIN/TOBRAMYCIN | Reference Gene Catalog | Established |
| P554L | - | elongation factor G FusA1 | Pseudomonas aeruginosa | AMIKACIN/TOBRAMYCINAminoglycoside | Reference Gene CatalogReslit | Confirmed |
| N592I | elongation factor G FusA1 | Pseudomonas aeruginosa, Acinetobacter baumannii | AMIKACIN/TOBRAMYCINAminoglycosideTobramycin+1 more | Reference Gene CatalogReslit | Confirmed |
| T671A | elongation factor G FusA1 | Pseudomonas aeruginosa, Acinetobacter baumannii | AMIKACIN/TOBRAMYCINAminoglycosideTobramycin+1 more | Reference Gene CatalogReslit | Confirmed |
| R680C | elongation factor G FusA1 | Pseudomonas aeruginosa, Acinetobacter baumannii | AMIKACIN/TOBRAMYCINTobramycin|Gentamicin|AmikacinTobramycin+1 more | Reference Gene CatalogReslit | Confirmed |
| L464V | - | elongation factor G FusA1 | Pseudomonas aeruginosa | AMIKACIN/TOBRAMYCIN | Reference Gene Catalog | Established |
| Y552C | - | elongation factor G FusA1, deleterious | Pseudomonas aeruginosa | AMIKACINAminoglycosideAmikacin | Reference Gene CatalogReslit | Confirmed |
| P618L | - | elongation factor G FusA1 | Pseudomonas aeruginosa | TOBRAMYCINAminoglycoside | Reference Gene CatalogReslit | Confirmed |
| I61M | - | elongation factor G FusA1 | Pseudomonas aeruginosa | Tobramycin|Gentamicin|AmikacinAminoglycosideAMIKACIN/TOBRAMYCIN | Reference Gene CatalogReslit | Confirmed |
| K504E | - | - | Pseudomonas aeruginosa | Aminoglycoside | Reslit | Candidate |
| V93A | - | Pseudomonas aeruginosa | AminoglycosideGentamicin|Amikacin|Tobramycin | Reslit | Supported |
| A555E | elongation factor G FusA1 | Pseudomonas aeruginosa | AminoglycosideAMIKACIN/TOBRAMYCINGentamicin|Amikacin|Tobramycin | Reference Gene CatalogReslit | Confirmed |
| G155D | - | - | Pseudomonas aeruginosa | Tobramycin | Reslit | Candidate |
| D588G | - | deleterious | Pseudomonas aeruginosa | AminoglycosideAmikacin | Reslit | Candidate |
| V338A | - | - | Pseudomonas aeruginosa | Aminoglycoside | Reslit | Candidate |
| Y683C | - | - | Pseudomonas aeruginosa | Aminoglycoside | Reslit | Candidate |
| A595V | - | - | Pseudomonas aeruginosa | Aminoglycoside | Reslit | Candidate |
| A481V | - | - | Pseudomonas aeruginosa | Aminoglycoside | Reslit | Candidate |
| P443L | - | altered conformation, stability, or dynamics | Pseudomonas aeruginosa | Gentamicin | Reslit | Candidate |
| L40Q | - | Pseudomonas aeruginosa | TobramycinGentamicin|Amikacin|Tobramycin | Reslit | Candidate |
| G611V | - | - | Pseudomonas aeruginosa | Tobramycin | Reslit | Candidate |
| A603V | - | - | Pseudomonas aeruginosa | Tobramycin | Reslit | Candidate |
| M461V | - | - | Pseudomonas aeruginosa | Tobramycin | Reslit | Candidate |
| R59H | - | - | Acinetobacter baumannii, Pseudomonas aeruginosa | Tobramycin | Reslit | Candidate |
| Q129H | - | - | Acinetobacter baumannii, Pseudomonas aeruginosa | Tobramycin | Reslit | Candidate |
| F596L | - | - | Acinetobacter baumannii, Pseudomonas aeruginosa | Tobramycin | Reslit | Candidate |
| G460V | - | - | Acinetobacter baumannii, Pseudomonas aeruginosa | Tobramycin | Reslit | Candidate |
| Q563L | - | - | Pseudomonas aeruginosa, Acinetobacter baumannii | Tobramycin | Reslit | Candidate |
| S459F | - | - | Pseudomonas aeruginosa | Tobramycin|Amikacin | Reslit | Candidate |
| L438Q | - | elongation factor G FusA1 | Pseudomonas aeruginosa | AMIKACIN/TOBRAMYCIN | Reference Gene Catalog | Established |
| R371C | elongation factor G FusA1 | Pseudomonas aeruginosa | AMIKACIN/TOBRAMYCINGentamicin|Amikacin|Tobramycin | Reference Gene CatalogReslit | Confirmed |
| T456A | elongation factor G FusA1 | Pseudomonas aeruginosa | AMIKACINGentamicin|Amikacin|Tobramycin | Reference Gene CatalogReslit | Confirmed |
| G545D | - | elongation factor G FusA1 | Pseudomonas aeruginosa | TOBRAMYCIN | Reference Gene Catalog | Established |
| I186V | - | Pseudomonas aeruginosa | Gentamicin|Amikacin|Tobramycin | Reslit | Candidate |
| - | - | Pseudomonas aeruginosa | Tobramycin | Reslit | Candidate |
| G118S | - | Pseudomonas aeruginosa | Gentamicin|Amikacin|Tobramycin | Reslit | Candidate |
| - | - | Pseudomonas aeruginosa | Tobramycin | Reslit | Candidate |
| - | - | Pseudomonas aeruginosa | Tobramycin | Reslit | Candidate |
A large-scale whole-genome comparison shows that experimental evolution in response to antibiotics predicts changes in naturally evolved clinical Pseudomonas aeruginosa.
fusA1
Mutations in Gene fusA1 as a Novel Mechanism of Aminoglycoside Resistance in Clinical Strains of Pseudomonas aeruginosa.
fusA1
Mutations in fusA1 were identified in both in vitro and clinical strains, and their role in aminoglycoside resistance was confirmed through various experimental approaches.
Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone.
fusA1
Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer.
fusA1
Pharmacodynamic Evaluation of Plasma and Epithelial Lining Fluid Exposures of Amikacin against Pseudomonas aeruginosa in a Dynamic In Vitro Hollow-Fiber Infection Model.
fusA1
Dynamics of Mutations during Development of Resistance by Pseudomonas aeruginosa against Five Antibiotics.
fusA1
The Versatile Mutational Resistome of Pseudomonas aeruginosa.
Evolution of the Pseudomonas aeruginosa Aminoglycoside Mutational Resistome In Vitro and in the Cystic Fibrosis Setting.
nonsynonymous mutations within this gene were detected in all five replicate experiments
fusA1
Hypermutator Pseudomonas aeruginosa Exploits Multiple Genetic Pathways To Develop Multidrug Resistance during Long-Term Infections in the Airways of Cystic Fibrosis Patients.
The predictive potential of different molecular markers linked to amikacin susceptibility phenotypes in Pseudomonas aeruginosa.
Global reprogramming of virulence and antibiotic resistance in Pseudomonas aeruginosa by a single nucleotide polymorphism in elongation factor, fusA1.
mutation in fusA1 leads to increased resistance and virulence
Triclosan depletes the membrane potential in Pseudomonas aeruginosa biofilms inhibiting aminoglycoside induced adaptive resistance.
Genome evolution drives transcriptomic and phenotypic adaptation in Pseudomonas aeruginosa during 20 years of infection.
The Effects of Sub-inhibitory Antibiotic Concentrations on Pseudomonas aeruginosa: Reduced Susceptibility Due to Mutations.
Gene-Gene Interactions Reduce Aminoglycoside Susceptibility of Pseudomonas aeruginosa through Efflux Pump-Dependent and -Independent Mechanisms.
Increases MIC by 4-fold
Parallel Evolution of Tobramycin Resistance across Species and Environments.
Mutations in fusA1 were found in both A. baumannii and P. aeruginosa, contributing to tobramycin resistance.
Keeping up with the pathogens: improved antimicrobial resistance detection and prediction from Pseudomonas aeruginosa genomes.
missense mutation
Evolution of Habitat-Dependent Antibiotic Resistance in Pseudomonas aeruginosa.
fusA1
Combining antibiotics with antivirulence compounds can have synergistic effects and reverse selection for antibiotic resistance in Pseudomonas aeruginosa.
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research